CellVoyant is a startup.
CellVoyant provides AI-driven software (FateView and FateDrive) that analyzes label-free cell images to predict current and future cell states and quality attributes, and simulates/optimises cell process conditions to guide experimental and manufacturing decisions for cell-based therapeutics.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.